Minocycline increases quality and longevity of chronic neural recordings

Brain/machine interfaces could potentially be used in the treatment of a host of neurological disorders ranging from paralysis to sensory deficits. Insertion of chronic micro-electrode arrays into neural tissue initiates a host of immunological responses, which typically leads to the formation of a cellular sheath around the implant, resulting in the loss of useful signals. Minocycline has been shown to have neuroprotective and neurorestorative effects in certain neural injury and neurodegenerative disease models. This study examined the effects of minocycline administration on the quality and longevity of chronic multi-channel microwire neural implants 1 week and 1 month post-implantation in auditory cortex. The mean signal-to-noise ratio for the minocycline group stabilized at the end of week 1 and remained above 4.6 throughout the following 3 weeks. The control group signal-to-noise ratio dropped throughout the duration of the study and at the end of 4 weeks was 2.6. Furthermore, 68% of electrodes from the minocycline group showed significant stimulus-driven activity at week 4 compared to 12.5% of electrodes in the control group. There was a significant reduction in the number of activated astrocytes around the implant in minocycline subjects, as well as a reduction in total area occupied by activated astrocytes at 1 and 4 weeks.

[1]  S. Retterer,et al.  Dexamethasone treatment reduces astroglia responses to inserted neuroprosthetic devices in rat neocortex , 2005, Experimental Neurology.

[2]  R. Hurlbert,et al.  Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. , 2003, Brain : a journal of neurology.

[3]  Betty Y. S. Kim,et al.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.

[4]  W. Walz,et al.  Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion , 2006, Brain Research.

[5]  D. Szarowski,et al.  Brain responses to micro-machined silicon devices , 2003, Brain Research.

[6]  Y. Oh,et al.  Minocycline inhibits apoptotic cell death via attenuation of TNF‐α expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co‐cultures , 2004, Journal of neurochemistry.

[7]  R L Schultz,et al.  The ultrastructure of the sheath around chronically implanted electrodes in brain , 1976, Journal of neurocytology.

[8]  D. Landis,et al.  The early reactions of non-neuronal cells to brain injury. , 1994, Annual review of neuroscience.

[9]  P. Tresco,et al.  Response of brain tissue to chronically implanted neural electrodes , 2005, Journal of Neuroscience Methods.

[10]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Szarowski,et al.  Cerebral Astrocyte Response to Micromachined Silicon Implants , 1999, Experimental Neurology.

[12]  R. Bonelli,et al.  Neuroprotection in Huntington's disease: a 2-year study on minocycline , 2004, International clinical psychopharmacology.

[13]  R. Rennaker,et al.  An economical multi-channel cortical electrode array for extended periods of recording during behavior , 2005, Journal of Neuroscience Methods.

[14]  D. Edell,et al.  Factors influencing the biocompatibility of insertable silicon microshafts in cerebral cortex , 1992, IEEE Transactions on Biomedical Engineering.

[15]  J. Muthuswamy,et al.  Brain micromotion around implants in the rodent somatosensory cortex , 2006, Journal of neural engineering.

[16]  R. L. Rennaker,et al.  A comparison of chronic multi-channel cortical implantation techniques: manual versus mechanical insertion , 2005, Journal of Neuroscience Methods.

[17]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[18]  S. Retterer,et al.  Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies , 2003, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[19]  S. Paul,et al.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Prasongchai Sattayaprasert,et al.  Minocycline inhibits neuronal death and glial activation induced by β‐amyloid peptide in rat hippocampus , 2004, Glia.

[21]  Karen L. Smith,et al.  Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion , 2006, Journal of neural engineering.